FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE

FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE was reported 60266 times

FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEART SOUNDS 55 0.5729
1 CENTRAL NERVOUS SYSTEM MASS 47 0.4947
2 SPIROMETRY ABNORMAL 292 0.4883
3 AIRWAY REMODELLING 58 0.4677
4 MITE ALLERGY 295 0.4504
5 WALL MOTION SCORE INDEX ABNORMAL 47 0.4273
6 DUST ALLERGY 333 0.3394
7 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 174 0.3327
8 MYCOTIC ALLERGY 278 0.3251
9 PROLONGED EXPIRATION 84 0.3206
10 BRONCHIAL NEOPLASM 40 0.2941
11 TOTAL LUNG CAPACITY ABNORMAL 114 0.2931
12 PULMONARY VASCULITIS 146 0.2714
13 CAPILLARITIS 69 0.2500
14 TOTAL LUNG CAPACITY INCREASED 66 0.2426
15 ATOPY 66 0.2374
16 FORCED EXPIRATORY VOLUME DECREASED 637 0.2246
17 TEMPERATURE REGULATION DISORDER 478 0.2143
18 CONJUNCTIVITIS ALLERGIC 300 0.2024
19 REVERSIBLE AIRWAYS OBSTRUCTION 100 0.1969
20 INHALATION THERAPY 123 0.1952
21 SMOKE SENSITIVITY 48 0.1558
22 LUNG DIFFUSION TEST DECREASED 62 0.1554
23 NASAL OEDEMA 274 0.1515
24 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 99 0.1351
25 BRONCHIAL HAEMORRHAGE 40 0.1282
26 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 260 0.1274
27 NASAL TURBINATE HYPERTROPHY 46 0.1220
28 BLOOD IMMUNOGLOBULIN E INCREASED 292 0.1205
29 OBSTRUCTIVE AIRWAYS DISORDER 1329 0.1194
30 FORCED VITAL CAPACITY DECREASED 77 0.1179
31 PERFUME SENSITIVITY 65 0.1142
32 ENDOMETRIAL ABLATION 40 0.1120
33 PEAK EXPIRATORY FLOW RATE DECREASED 47 0.1068
34 EOSINOPHIL COUNT ABNORMAL 79 0.1058
35 NEURITIS 160 0.1036
36 LUNG HYPERINFLATION 86 0.1000
37 HOARSENESS 47 0.0975
38 RESTRICTIVE PULMONARY DISEASE 114 0.0973
39 RESPIRATORY SYMPTOM 276 0.0969
40 SPUTUM DISCOLOURED 844 0.0889
41 NORMOCHROMIC NORMOCYTIC ANAEMIA 260 0.0865
42 FOOD ALLERGY 666 0.0862
43 PULMONARY FUNCTION TEST ABNORMAL 130 0.0834
44 NASAL DISCHARGE DISCOLOURATION 113 0.0819
45 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1381 0.0812
46 RHONCHI 112 0.0810
47 OXYGEN SUPPLEMENTATION 57 0.0770
48 ALLERGY TO ANIMAL 82 0.0769
49 ASTHMA 8223 0.0727
50 WHEEZING 4239 0.0714
51 BRONCHIAL WALL THICKENING 51 0.0709
52 EMERGENCY CARE EXAMINATION 47 0.0693
53 EOSINOPHILIC MYOCARDITIS 49 0.0671
54 CARDIAC SEPTAL DEFECT 48 0.0668
55 PULMONARY FUNCTION TEST DECREASED 292 0.0666
56 INCREASED VISCOSITY OF BRONCHIAL SECRETION 42 0.0658
57 TOTAL LUNG CAPACITY DECREASED 105 0.0657
58 ADRENAL SUPPRESSION 55 0.0652
59 BRONCHIAL HYPERREACTIVITY 77 0.0640
60 SPUTUM PURULENT 42 0.0638
61 FULL BLOOD COUNT ABNORMAL 661 0.0624
62 ALLERGIC GRANULOMATOUS ANGIITIS 51 0.0621
63 LOWER RESPIRATORY TRACT CONGESTION 105 0.0617
64 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 334 0.0613
65 BREATH SOUNDS ABNORMAL 296 0.0600
66 BRONCHIAL DISORDER 90 0.0578
67 MULTI-ORGAN DISORDER 111 0.0564
68 BRONCHIECTASIS 377 0.0559
69 SINUS PAIN 127 0.0544
70 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 48 0.0538
71 FOETAL DEATH 277 0.0534
72 CHRONIC SINUSITIS 200 0.0532
73 MICROANGIOPATHY 50 0.0532
74 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 49 0.0529
75 NASAL POLYPS 260 0.0527
76 NASAL OBSTRUCTION 97 0.0517
77 SPUTUM RETENTION 51 0.0515
78 HYPOVENTILATION 163 0.0500
79 RESPIRATORY TRACT IRRITATION 52 0.0498
80 COELIAC DISEASE 484 0.0493
81 RALES 273 0.0470
82 IMMUNODEFICIENCY 680 0.0456
83 BRONCHIAL OBSTRUCTION 64 0.0456
84 PRODUCTIVE COUGH 2152 0.0450
85 ARTERIOSCLEROSIS CORONARY ARTERY 294 0.0443
86 INVESTIGATION 139 0.0443
87 BLOOD COUNT ABNORMAL 662 0.0436
88 CYSTIC FIBROSIS 232 0.0419
89 INCREASED BRONCHIAL SECRETION 105 0.0410
90 EOSINOPHIL COUNT INCREASED 337 0.0404
91 BURSITIS 490 0.0403
92 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2001 0.0383
93 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 40 0.0377
94 NOCTURNAL DYSPNOEA 48 0.0376
95 SPUTUM INCREASED 80 0.0370
96 BLOOD PRESSURE SYSTOLIC ABNORMAL 91 0.0368
97 BLOOD PRESSURE DIASTOLIC ABNORMAL 89 0.0350
98 RHINITIS ALLERGIC 152 0.0341
99 EMPHYSEMA 341 0.0338
100 UPPER-AIRWAY COUGH SYNDROME 275 0.0333
101 RESPIRATORY TRACT INFECTION 869 0.0333
102 BRONCHIAL SECRETION RETENTION 42 0.0330
103 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1583 0.0329
104 THROAT CLEARING 123 0.0328
105 SENSITIVITY TO WEATHER CHANGE 171 0.0325
106 MYCOBACTERIUM AVIUM COMPLEX INFECTION 87 0.0324
107 RESPIRATORY TRACT CONGESTION 491 0.0309
108 RESPIRATORY RATE INCREASED 265 0.0298
109 DYSPNOEA EXERTIONAL 1117 0.0296
110 ARTERIOSCLEROSIS 278 0.0295
111 INFUSION SITE DISCHARGE 51 0.0291
112 NEPHROGENIC ANAEMIA 133 0.0287
113 PULMONARY ALVEOLAR HAEMORRHAGE 161 0.0287
114 CARBON DIOXIDE INCREASED 39 0.0286
115 NODULE 371 0.0284
116 MIDDLE INSOMNIA 530 0.0284
117 BODY TEMPERATURE DECREASED 277 0.0281
118 NASAL DISORDER 74 0.0278
119 RHINITIS 223 0.0276
120 NEUROLOGICAL SYMPTOM 158 0.0276
121 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1960 0.0275
122 MULTIPLE ALLERGIES 214 0.0273
123 UPPER RESPIRATORY TRACT INFECTION 1260 0.0272
124 SINUS OPERATION 64 0.0268
125 HYPERPARATHYROIDISM SECONDARY 67 0.0267
126 SEASONAL ALLERGY 376 0.0265
127 LUNG OPACITY 70 0.0265
128 CREPITATIONS 79 0.0265
129 REBOUND ACID HYPERSECRETION 78 0.0258
130 RESPIRATION ABNORMAL 177 0.0257
131 EOSINOPHIL COUNT DECREASED 61 0.0256
132 APHONIA 355 0.0254
133 PULMONARY PAIN 74 0.0253
134 PRESCRIBED OVERDOSE 487 0.0251
135 ORAL CANDIDIASIS 327 0.0248
136 VOCAL CORD DISORDER 48 0.0243
137 BRONCHITIS CHRONIC 59 0.0241
138 BLOOD PRESSURE SYSTOLIC INCREASED 463 0.0237
139 LUNG INFECTION 367 0.0236
140 PULMONARY MASS 347 0.0233
141 SECRETION DISCHARGE 289 0.0231
142 DYSPHONIA 1293 0.0221
143 TACHYARRHYTHMIA 55 0.0220
144 BRONCHITIS 1628 0.0220
145 PHARMACEUTICAL PRODUCT COMPLAINT 568 0.0219
146 DEPRESSIVE SYMPTOM 77 0.0218
147 PAINFUL RESPIRATION 52 0.0215
148 LUNG CONSOLIDATION 60 0.0214
149 PARANASAL SINUS DISCOMFORT 79 0.0208
150 VENTRICULAR HYPOKINESIA 67 0.0208
151 OXYGEN SATURATION ABNORMAL 59 0.0208
152 SNORING 78 0.0206
153 SARCOIDOSIS 98 0.0206
154 CANDIDIASIS 82 0.0204
155 RESPIRATORY DISORDER 590 0.0197
156 INFUSION SITE PRURITUS 62 0.0196
157 LUNG DISORDER 960 0.0196
158 CANDIDA INFECTION 323 0.0191
159 NASAL CONGESTION 1117 0.0190
160 INFUSION SITE BRUISING 40 0.0185
161 LOWER RESPIRATORY TRACT INFECTION 830 0.0182
162 CHEST DISCOMFORT 1864 0.0182
163 SINUS CONGESTION 244 0.0180
164 DYSPNOEA 10067 0.0178
165 PRE-EXISTING CONDITION IMPROVED 111 0.0178
166 COUGH 4984 0.0178
167 INFUSION SITE HAEMORRHAGE 58 0.0176
168 PRODUCT CLEANING INADEQUATE 47 0.0176
169 HAEMOPTYSIS 490 0.0175
170 POLYP 114 0.0174
171 RESPIRATORY TRACT INFECTION VIRAL 40 0.0172
172 SINUS DISORDER 339 0.0171
173 IMPAIRED QUALITY OF LIFE 245 0.0170
174 ENDOTRACHEAL INTUBATION 47 0.0167
175 DRUG ADMINISTRATION ERROR 514 0.0167
176 INCREASED UPPER AIRWAY SECRETION 85 0.0165
177 EOSINOPHILIC PNEUMONIA 52 0.0165
178 OXYGEN SATURATION DECREASED 925 0.0164
179 ORAL FUNGAL INFECTION 45 0.0164
180 INFUSION SITE SWELLING 103 0.0164
181 FLUID RETENTION 829 0.0163
182 OEDEMA 876 0.0161
183 PULMONARY CONGESTION 212 0.0161
184 VIRAL UPPER RESPIRATORY TRACT INFECTION 76 0.0160
185 REHABILITATION THERAPY 61 0.0157
186 SLEEP APNOEA SYNDROME 298 0.0156
187 SINUSITIS 1595 0.0155
188 DYSPNOEA AT REST 45 0.0155
189 EMERGENCY CARE 47 0.0155
190 PNEUMONIA 4989 0.0154
191 VASCULITIS 179 0.0154
192 GINGIVAL DISORDER 59 0.0153
193 BLOOD IMMUNOGLOBULIN G DECREASED 38 0.0153
194 CATARACT OPERATION 91 0.0153
195 APPETITE DISORDER 100 0.0151
196 HYPERCAPNIA 45 0.0149
197 PHARYNGOLARYNGEAL PAIN 79 0.0148
198 RASH ERYTHEMATOUS 706 0.0148
199 OBESITY 233 0.0146
200 PHARYNGEAL DISORDER 41 0.0142
201 HYPOXIA 499 0.0142
202 RHINORRHOEA 913 0.0141
203 INTENTIONAL UNDERDOSE 102 0.0139
204 CHOKING SENSATION 77 0.0139
205 INTENTIONAL DEVICE MISUSE 61 0.0138
206 BLOOD PRESSURE DIASTOLIC DECREASED 102 0.0138
207 PULMONARY FIBROSIS 263 0.0137
208 HAEMORRHAGIC ANAEMIA 60 0.0136
209 SNEEZING 306 0.0136
210 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 97 0.0135
211 RED CELL DISTRIBUTION WIDTH INCREASED 56 0.0135
212 UPPER RESPIRATORY TRACT CONGESTION 39 0.0135
213 DECREASED ACTIVITY 145 0.0134
214 END STAGE RENAL DISEASE 245 0.0134
215 LUNG TRANSPLANT 47 0.0133
216 THYROID DISORDER 204 0.0132
217 AORTIC STENOSIS 46 0.0132
218 INFLUENZA 1469 0.0132
219 CONTRAINDICATED PRODUCT ADMINISTERED 398 0.0131
220 ARTHRITIS INFECTIVE 60 0.0129
221 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 604 0.0129
222 VIRAL INFECTION 424 0.0127
223 GRANULOMA 44 0.0127
224 SKIN ABRASION 60 0.0127
225 PRODUCT COMPLAINT 321 0.0127
226 LIGAMENT SPRAIN 124 0.0125
227 PNEUMONIA BACTERIAL 115 0.0125
228 INFUSION SITE ERYTHEMA 105 0.0124
229 MALNUTRITION 138 0.0123
230 PARANASAL SINUS HYPERSECRETION 47 0.0123
231 DRY THROAT 125 0.0123
232 OROPHARYNGEAL DISCOMFORT 110 0.0122
233 PSEUDOMONAS INFECTION 103 0.0120
234 PRODUCT QUALITY ISSUE 1622 0.0119
235 HEART RATE INCREASED 1178 0.0119
236 ASPHYXIA 97 0.0119
237 THROAT IRRITATION 532 0.0118
238 EXERCISE TOLERANCE DECREASED 68 0.0118
239 HAEMORRHAGIC DIATHESIS 42 0.0118
240 NASOPHARYNGITIS 2173 0.0118
241 EAR INFECTION 312 0.0117
242 PROSTATOMEGALY 46 0.0117
243 CONCUSSION 90 0.0116
244 INABILITY TO AFFORD MEDICATION 115 0.0116
245 EAR PAIN 225 0.0116
246 CHRONIC KIDNEY DISEASE 877 0.0115
247 EYE HAEMORRHAGE 154 0.0115
248 ADRENAL INSUFFICIENCY 140 0.0115
249 TOOTH ABSCESS 117 0.0115
250 OROPHARYNGEAL PAIN 1047 0.0113
251 SKIN LACERATION 122 0.0112
252 MACULAR DEGENERATION 133 0.0111
253 HIATUS HERNIA 144 0.0111
254 HYPERVENTILATION 64 0.0110
255 SPINAL OSTEOARTHRITIS 97 0.0110
256 CARDIAC MURMUR 95 0.0110
257 ASTHMATIC CRISIS 40 0.0109
258 UMBILICAL HERNIA 51 0.0109
259 IRON DEFICIENCY 49 0.0109
260 LIGAMENT RUPTURE 48 0.0109
261 WHEELCHAIR USER 48 0.0108
262 HEPATIC ENZYME INCREASED 734 0.0108
263 BODY HEIGHT DECREASED 115 0.0107
264 ABDOMINAL HERNIA 49 0.0107
265 RIB FRACTURE 219 0.0106
266 FOOD POISONING 57 0.0106
267 INCORRECT DOSAGE ADMINISTERED 52 0.0106
268 BLOOD PRESSURE DIASTOLIC INCREASED 49 0.0106
269 ACUTE RESPIRATORY FAILURE 204 0.0106
270 ORAL DISORDER 77 0.0105
271 INFUSION RELATED REACTION 692 0.0104
272 DECREASED IMMUNE RESPONSIVENESS 101 0.0103
273 PULMONARY THROMBOSIS 112 0.0103
274 OBSTRUCTION 41 0.0103
275 INFUSION SITE PAIN 132 0.0102
276 BRONCHOSPASM 146 0.0102
277 HYPOTHYROIDISM 326 0.0102
278 PHARYNGITIS 126 0.0101
279 OESOPHAGEAL CANDIDIASIS 40 0.0100
280 BLOOD TEST ABNORMAL 141 0.0100
281 FOOT FRACTURE 190 0.0100
282 RHINOVIRUS INFECTION 39 0.0100
283 ABNORMAL LOSS OF WEIGHT 68 0.0100
284 INTENTIONAL PRODUCT MISUSE 872 0.0100
285 MUSCULOSKELETAL CHEST PAIN 154 0.0099
286 OSTEOPENIA 150 0.0099
287 ANKLE FRACTURE 153 0.0099
288 JOINT INJURY 209 0.0098
289 PLEURISY 58 0.0098
290 CATARACT 580 0.0097
291 GASTROOESOPHAGEAL REFLUX DISEASE 784 0.0097
292 LOWER GASTROINTESTINAL HAEMORRHAGE 71 0.0096
293 FLANK PAIN 90 0.0096
294 HYPERSENSITIVITY 1773 0.0095
295 STENT PLACEMENT 77 0.0095
296 AFFECTIVE DISORDER 75 0.0095
297 CHEST PAIN 1748 0.0094
298 PRODUCT ADMINISTRATION INTERRUPTED 74 0.0094
299 HYPERCHOLESTEROLAEMIA 91 0.0094
300 SKIN ATROPHY 54 0.0094
301 EXPOSURE DURING PREGNANCY 582 0.0094
302 DEVICE USE ERROR 325 0.0093
303 INTERVERTEBRAL DISC DEGENERATION 86 0.0093
304 CHOKING 181 0.0093
305 GASTROENTERITIS VIRAL 166 0.0092
306 WRIST FRACTURE 110 0.0092
307 HAND FRACTURE 65 0.0092
308 RETCHING 195 0.0091
309 BACTERIAL INFECTION 170 0.0091
310 EOSINOPHILIA 159 0.0091
311 LIMB INJURY 246 0.0090
312 MUSCLE STRAIN 78 0.0090
313 HORDEOLUM 39 0.0090
314 EAR DISCOMFORT 92 0.0090
315 CARDIAC OPERATION 77 0.0089
316 AORTIC ANEURYSM 68 0.0089
317 INFECTION 1293 0.0089
318 VITAMIN D DEFICIENCY 87 0.0089
319 CONCOMITANT DISEASE AGGRAVATED 55 0.0089
320 BENIGN PROSTATIC HYPERPLASIA 46 0.0089
321 INTERVERTEBRAL DISC DISORDER 38 0.0089
322 BLOOD PRESSURE INCREASED 1346 0.0088
323 ATELECTASIS 85 0.0088
324 BACK INJURY 95 0.0087
325 GLAUCOMA 168 0.0087
326 LUNG NEOPLASM MALIGNANT 358 0.0087
327 SPINAL COMPRESSION FRACTURE 72 0.0087
328 POST-TRAUMATIC STRESS DISORDER 58 0.0086
329 MENISCUS INJURY 53 0.0086
330 PERICARDIAL EFFUSION 199 0.0086
331 DERMATITIS CONTACT 98 0.0086
332 TENDERNESS 89 0.0085
333 HERNIA 165 0.0085
334 EAR DISORDER 39 0.0085
335 GOUT 152 0.0085
336 PNEUMOTHORAX 134 0.0084
337 RHEUMATOID ARTHRITIS 958 0.0084
338 FRUSTRATION TOLERANCE DECREASED 68 0.0084
339 ILL-DEFINED DISORDER 511 0.0084
340 OSTEOPOROSIS 346 0.0084
341 FEELING JITTERY 160 0.0084
342 PSYCHOLOGICAL TRAUMA 72 0.0083
343 STRESS FRACTURE 45 0.0083
344 PHARYNGITIS STREPTOCOCCAL 90 0.0083
345 MALAISE 3642 0.0083
346 GLUCOSE TOLERANCE IMPAIRED 49 0.0083
347 ATRIAL FLUTTER 66 0.0083
348 RESPIRATORY SYNCYTIAL VIRUS INFECTION 72 0.0083
349 MUSCULOSKELETAL DISCOMFORT 142 0.0082
350 POST PROCEDURAL INFECTION 67 0.0082
351 INTERVERTEBRAL DISC PROTRUSION 180 0.0082
352 CORONARY ARTERY BYPASS 47 0.0082
353 HEART RATE IRREGULAR 183 0.0081
354 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 41 0.0081
355 SINUS HEADACHE 48 0.0081
356 DIABETIC NEUROPATHY 40 0.0081
357 THROAT TIGHTNESS 218 0.0081
358 SCRATCH 85 0.0081
359 BLOOD PRESSURE FLUCTUATION 192 0.0080
360 POOR QUALITY SLEEP 172 0.0080
361 NASAL DRYNESS 50 0.0080
362 THROMBOSIS 638 0.0079
363 PULMONARY HYPERTENSION 165 0.0079
364 NERVE COMPRESSION 73 0.0079
365 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 48 0.0079
366 ASPIRATION 86 0.0078
367 CARDIAC FAILURE CONGESTIVE 630 0.0078
368 ASPERGILLUS INFECTION 51 0.0078
369 HYPERHIDROSIS 997 0.0077
370 ACCIDENT 92 0.0077
371 ORAL PAIN 172 0.0077
372 INSURANCE ISSUE 117 0.0076
373 WEIGHT DECREASED 2129 0.0076
374 FIBROMYALGIA 185 0.0076
375 GASTROENTERITIS 111 0.0076
376 ROTATOR CUFF SYNDROME 97 0.0075
377 INFUSION SITE EXTRAVASATION 47 0.0075
378 EYE PRURITUS 253 0.0075
379 HEART RATE DECREASED 264 0.0075
380 ARTHRITIS 590 0.0075
381 BLOOD IRON DECREASED 89 0.0075
382 TROPONIN INCREASED 57 0.0075
383 UPPER LIMB FRACTURE 149 0.0075
384 LACERATION 70 0.0074
385 HYPERTENSION 1573 0.0074
386 ILLNESS 765 0.0074
387 CONTUSION 711 0.0074
388 BACK PAIN 1711 0.0074
389 JOINT SWELLING 889 0.0074
390 TOOTH INFECTION 97 0.0074
391 PANIC REACTION 53 0.0073
392 PULMONARY OEDEMA 328 0.0073
393 MYASTHENIA GRAVIS 59 0.0073
394 DIVERTICULITIS 202 0.0073
395 JOINT DISLOCATION 77 0.0073
396 WALKING AID USER 48 0.0073
397 FUNGAL INFECTION 242 0.0073
398 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 64 0.0072
399 LOCALISED INFECTION 175 0.0072
400 OSTEOARTHRITIS 306 0.0072
401 HIP SURGERY 39 0.0072
402 SLEEP DISORDER 508 0.0072
403 EYE INFECTION 80 0.0071
404 UNDERDOSE 516 0.0071
405 DRUG INTOLERANCE 682 0.0071
406 DENTAL CARIES 78 0.0070
407 FACIAL PAIN 62 0.0069
408 HERPES ZOSTER 398 0.0069
409 HOSPITALISATION 1062 0.0069
410 PNEUMONITIS 188 0.0069
411 SPINAL OPERATION 85 0.0069
412 WEIGHT FLUCTUATION 72 0.0069
413 KIDNEY INFECTION 135 0.0069
414 SOMNAMBULISM 45 0.0068
415 CYSTITIS 218 0.0068
416 SINUS TACHYCARDIA 97 0.0068
417 TYPE 2 DIABETES MELLITUS 229 0.0068
418 POOR VENOUS ACCESS 70 0.0068
419 ARTHROPOD BITE 50 0.0067
420 INCREASED TENDENCY TO BRUISE 62 0.0067
421 ECZEMA 349 0.0067
422 WEIGHT INCREASED 1489 0.0066
423 TOOTH FRACTURE 73 0.0066
424 LACRIMATION INCREASED 200 0.0066
425 SCOLIOSIS 41 0.0066
426 NECK PAIN 366 0.0065
427 NEPHROPATHY 61 0.0065
428 DIABETES MELLITUS 498 0.0065
429 ROAD TRAFFIC ACCIDENT 273 0.0065
430 POSTOPERATIVE WOUND INFECTION 44 0.0065
431 SARS-COV-2 TEST POSITIVE 86 0.0065
432 EYE DISORDER 214 0.0065
433 IRON DEFICIENCY ANAEMIA 60 0.0065
434 BLOOD CALCIUM INCREASED 57 0.0065
435 TONGUE DISORDER 47 0.0065
436 RESPIRATORY DISTRESS 179 0.0065
437 PERIPHERAL SWELLING 996 0.0065
438 NEPHROLITHIASIS 296 0.0064
439 HIP FRACTURE 207 0.0064
440 DEVICE DELIVERY SYSTEM ISSUE 176 0.0064
441 SKIN INFECTION 72 0.0064
442 BLOOD POTASSIUM DECREASED 192 0.0064
443 THERAPEUTIC RESPONSE DECREASED 387 0.0064
444 DRUG DOSE OMISSION 1055 0.0064
445 EXPIRED PRODUCT ADMINISTERED 212 0.0064
446 ODYNOPHAGIA 38 0.0064
447 CONJUNCTIVITIS 118 0.0064
448 RIGHT VENTRICULAR FAILURE 44 0.0063
449 ORAL DISCOMFORT 87 0.0063
450 DRY MOUTH 506 0.0062
451 PAROSMIA 47 0.0062
452 IMMUNE SYSTEM DISORDER 82 0.0062
453 ANOSMIA 90 0.0062
454 CARPAL TUNNEL SYNDROME 87 0.0062
455 PRODUCT USE ISSUE 1167 0.0062
456 APPENDICITIS 58 0.0062
457 NERVE INJURY 69 0.0062
458 RENAL INJURY 184 0.0062
459 BODY TEMPERATURE INCREASED 125 0.0061
460 WOUND INFECTION 67 0.0061
461 PHARYNGEAL OEDEMA 94 0.0061
462 SPINAL FRACTURE 122 0.0061
463 NEURALGIA 148 0.0061
464 PULMONARY EMBOLISM 576 0.0061
465 CELLULITIS 305 0.0060
466 RENAL CYST 48 0.0060
467 INTERNAL HAEMORRHAGE 69 0.0060
468 CARDIAC FLUTTER 39 0.0060
469 PHARYNGEAL SWELLING 59 0.0060
470 TOOTHACHE 109 0.0060
471 STAPHYLOCOCCAL INFECTION 198 0.0060
472 FALL 1995 0.0060
473 SKIN LESION 164 0.0060
474 VITAMIN D DECREASED 51 0.0060
475 CYST 74 0.0060
476 HYPOPHOSPHATAEMIA 44 0.0059
477 NERVOUSNESS 310 0.0059
478 MUSCLE DISORDER 48 0.0059
479 BONE DISORDER 108 0.0059
480 DIVERTICULUM 42 0.0059
481 GINGIVAL PAIN 47 0.0059
482 PULMONARY ARTERIAL HYPERTENSION 85 0.0059
483 ULCER 93 0.0058
484 HEADACHE 3663 0.0058
485 CORONARY ARTERY OCCLUSION 80 0.0058
486 QUALITY OF LIFE DECREASED 78 0.0058
487 EXOSTOSIS 53 0.0058
488 CONSTIPATION 1264 0.0058
489 CHOLECYSTECTOMY 66 0.0058
490 LUNG INFILTRATION 51 0.0058
491 TENDONITIS 89 0.0057
492 LOWER LIMB FRACTURE 110 0.0057
493 BACK DISORDER 93 0.0057
494 CONDITION AGGRAVATED 1733 0.0057
495 CARDIOMEGALY 70 0.0057
496 HYPERSOMNIA 163 0.0057
497 THERAPEUTIC RESPONSE UNEXPECTED 255 0.0057
498 ANAPHYLACTIC REACTION 314 0.0057
499 BLOOD SODIUM DECREASED 107 0.0057
500 PYREXIA 1964 0.0057
501 FEEDING DISORDER 115 0.0057
502 GASTROINTESTINAL HAEMORRHAGE 473 0.0057
503 BLADDER DISORDER 56 0.0056
504 CLOSTRIDIUM DIFFICILE INFECTION 123 0.0056
505 TRANSIENT ISCHAEMIC ATTACK 190 0.0056
506 BOWEL MOVEMENT IRREGULARITY 43 0.0056
507 SCAR 96 0.0056
508 URTICARIA 939 0.0056
509 SPINAL DISORDER 53 0.0056
510 HEREDITARY ANGIOEDEMA 60 0.0056
511 HAIR DISORDER 46 0.0056
512 PAIN 3429 0.0056
513 DISABILITY 110 0.0056
514 LIMB DISCOMFORT 172 0.0056
515 SURGERY 325 0.0055
516 TREATMENT NONCOMPLIANCE 303 0.0055
517 MIGRAINE 528 0.0055
518 ANXIETY 1574 0.0055
519 HYPERLIPIDAEMIA 66 0.0055
520 IMPAIRED GASTRIC EMPTYING 75 0.0055
521 PRODUCT DOSE OMISSION 359 0.0055
522 INTENTIONAL PRODUCT USE ISSUE 481 0.0055
523 ECONOMIC PROBLEM 83 0.0055
524 POST PROCEDURAL COMPLICATION 105 0.0055
525 URINARY TRACT INFECTION 931 0.0055
526 TRANSFUSION 57 0.0054
527 HEPATIC STEATOSIS 101 0.0054
528 KNEE ARTHROPLASTY 114 0.0054
529 WOUND 151 0.0054
530 WHITE BLOOD CELL COUNT INCREASED 207 0.0054
531 DISCOMFORT 328 0.0054
532 MASS 75 0.0054
533 RENAL FAILURE 711 0.0053
534 ATRIAL FIBRILLATION 521 0.0053
535 PARAESTHESIA ORAL 77 0.0053
536 INTESTINAL OBSTRUCTION 201 0.0053
537 SKIN HAEMORRHAGE 79 0.0053
538 TEMPERATURE INTOLERANCE 55 0.0053
539 EPISTAXIS 397 0.0053
540 SWELLING 496 0.0053
541 INFLUENZA LIKE ILLNESS 436 0.0053
542 PRODUCT DISTRIBUTION ISSUE 49 0.0053
543 CARDIAC DISORDER 494 0.0053
544 PAIN IN EXTREMITY 1551 0.0053
545 MUSCULOSKELETAL PAIN 275 0.0052
546 ERYTHEMA 1076 0.0052
547 INSOMNIA 1392 0.0052
548 RESTLESS LEGS SYNDROME 95 0.0052
549 SENSATION OF FOREIGN BODY 44 0.0052
550 PALPITATIONS 611 0.0052
551 GALLBLADDER DISORDER 93 0.0052
552 OEDEMA PERIPHERAL 634 0.0052
553 RENAL TUBULAR NECROSIS 51 0.0052
554 BLOOD CHOLESTEROL INCREASED 242 0.0052
555 HAEMORRHOIDS 100 0.0051
556 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 920 0.0051
557 BLOOD PRESSURE DECREASED 339 0.0051
558 FATIGUE 3968 0.0051
559 ANGINA PECTORIS 146 0.0051
560 CHILLS 597 0.0051
561 SCAB 58 0.0051
562 KNEE OPERATION 50 0.0051
563 HYPOACUSIS 218 0.0051
564 DYSPHAGIA 479 0.0050
565 HEAD INJURY 159 0.0050
566 TENDON RUPTURE 62 0.0050
567 FLUID OVERLOAD 73 0.0050
568 COVID-19 PNEUMONIA 59 0.0050
569 ANHEDONIA 131 0.0050
570 BLOOD MAGNESIUM DECREASED 43 0.0050
571 RASH PRURITIC 270 0.0050
572 SPEECH DISORDER 261 0.0050
573 NEUTROPHIL COUNT INCREASED 51 0.0050
574 ARTERIAL OCCLUSIVE DISEASE 39 0.0050
575 VENTRICULAR FIBRILLATION 55 0.0049
576 DIZZINESS POSTURAL 48 0.0049
577 DRUG EFFECT INCOMPLETE 179 0.0049
578 EYE DISCHARGE 51 0.0049
579 DRY EYE 245 0.0049
580 TOOTH DISORDER 109 0.0049
581 BLOOD URINE PRESENT 93 0.0049
582 HIP ARTHROPLASTY 75 0.0049
583 SCIATICA 78 0.0049
584 DYSPEPSIA 481 0.0049
585 SMALL INTESTINAL OBSTRUCTION 60 0.0049
586 GASTRIC ULCER 92 0.0048
587 COVID-19 849 0.0048
588 LIP SWELLING 161 0.0048
589 MICTURITION URGENCY 55 0.0048
590 HEAD DISCOMFORT 85 0.0048
591 NOCTURIA 58 0.0048
592 COLD SWEAT 84 0.0048
593 TREMOR 789 0.0047
594 PANIC ATTACK 173 0.0047
595 ESCHERICHIA INFECTION 39 0.0047
596 MEMORY IMPAIRMENT 650 0.0047
597 GAIT INABILITY 158 0.0047
598 CHOLELITHIASIS 155 0.0047
599 ORAL HERPES 92 0.0047
600 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 952 0.0047
601 PRODUCT DOSE OMISSION ISSUE 1380 0.0047
602 VOMITING 2205 0.0047
603 GASTROINTESTINAL INFECTION 42 0.0047
604 FEELING COLD 130 0.0047
605 HAIR TEXTURE ABNORMAL 62 0.0046
606 ACUTE KIDNEY INJURY 706 0.0046
607 INITIAL INSOMNIA 47 0.0046
608 HAIR COLOUR CHANGES 57 0.0046
609 PRODUCT TASTE ABNORMAL 62 0.0046
610 ASTHENIA 1721 0.0046
611 RETINAL DETACHMENT 42 0.0046
612 MYALGIA 776 0.0046
613 TREATMENT FAILURE 378 0.0046
614 MUSCLE SPASMS 837 0.0046
615 ARTHRALGIA 1896 0.0046
616 ANAL INCONTINENCE 41 0.0046
617 HOSPICE CARE 45 0.0046
618 GROIN PAIN 40 0.0046
619 FEELING ABNORMAL 1090 0.0045
620 DERMATITIS ATOPIC 239 0.0045
621 BIPOLAR DISORDER 49 0.0045
622 MUSCLE ATROPHY 57 0.0045
623 GAIT DISTURBANCE 861 0.0045
624 EUPHORIC MOOD 46 0.0045
625 PAIN IN JAW 127 0.0045
626 DEPRESSED MOOD 237 0.0045
627 DEVICE FAILURE 68 0.0045
628 RESPIRATORY FAILURE 325 0.0045
629 DRUG DISPENSING ERROR 68 0.0044
630 RASH 1939 0.0044
631 RENAL DISORDER 206 0.0044
632 PHOTOSENSITIVITY REACTION 73 0.0044
633 EYE SWELLING 164 0.0044
634 THINKING ABNORMAL 82 0.0044
635 UPPER GASTROINTESTINAL HAEMORRHAGE 74 0.0044
636 MUSCULOSKELETAL STIFFNESS 385 0.0044
637 PRURITUS GENERALISED 95 0.0044
638 COAGULOPATHY 73 0.0044
639 VERTIGO 267 0.0044
640 GASTRIC DISORDER 150 0.0044
641 AGEUSIA 109 0.0044
642 DIZZINESS 2173 0.0044
643 CARDIOMYOPATHY 64 0.0043
644 DEMENTIA 121 0.0043
645 BLOOD PRESSURE ABNORMAL 86 0.0043
646 SWELLING FACE 280 0.0043
647 PSORIASIS 561 0.0043
648 SKIN DISORDER 143 0.0043
649 ABDOMINAL DISCOMFORT 718 0.0043
650 TUBULOINTERSTITIAL NEPHRITIS 80 0.0043
651 DYSURIA 157 0.0043
652 UNRESPONSIVE TO STIMULI 110 0.0043
653 RECTAL HAEMORRHAGE 183 0.0043
654 DISEASE RECURRENCE 202 0.0042
655 MOVEMENT DISORDER 136 0.0042
656 PLATELET COUNT INCREASED 55 0.0042
657 AUTOIMMUNE DISORDER 41 0.0042
658 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 72 0.0042
659 DRUG INEFFECTIVE 5535 0.0042
660 RED BLOOD CELL COUNT DECREASED 120 0.0042
661 RESPIRATORY ARREST 115 0.0042
662 SWOLLEN TONGUE 130 0.0042
663 NIGHT SWEATS 134 0.0042
664 INFLAMMATION 214 0.0041
665 NEUROPATHY PERIPHERAL 394 0.0041
666 ABDOMINAL PAIN UPPER 852 0.0041
667 HAEMATOCRIT DECREASED 82 0.0041
668 LEUKAEMIA 39 0.0041
669 BEDRIDDEN 54 0.0041
670 OVARIAN CYST 41 0.0041
671 EYE INFLAMMATION 39 0.0041
672 DYSGEUSIA 303 0.0041
673 BALANCE DISORDER 352 0.0041
674 VITREOUS FLOATERS 40 0.0041
675 INTENTIONAL DOSE OMISSION 116 0.0041
676 INCONTINENCE 43 0.0041
677 FOOT DEFORMITY 45 0.0041
678 PRESYNCOPE 98 0.0040
679 PLEURAL EFFUSION 245 0.0040
680 IMPAIRED WORK ABILITY 86 0.0040
681 MUSCLE TIGHTNESS 65 0.0040
682 ABASIA 99 0.0040
683 THERAPY CESSATION 205 0.0040
684 LOSS OF CONSCIOUSNESS 511 0.0040
685 PHOTOPHOBIA 75 0.0040
686 OVERDOSE 860 0.0040
687 TACHYPNOEA 54 0.0040
688 MOBILITY DECREASED 285 0.0040
689 PRODUCT PHYSICAL ISSUE 80 0.0040
690 ABDOMINAL PAIN 921 0.0040
691 MULTIPLE FRACTURES 65 0.0040
692 THROMBOCYTOPENIA 440 0.0039
693 FEELING HOT 241 0.0039
694 LYMPHADENOPATHY 139 0.0039
695 DEVICE MALFUNCTION 275 0.0039
696 LIVER FUNCTION TEST INCREASED 84 0.0039
697 BASAL CELL CARCINOMA 61 0.0039
698 ARTHROPATHY 217 0.0039
699 SKIN DISCOLOURATION 179 0.0039
700 TACHYCARDIA 346 0.0039
701 GLOSSODYNIA 87 0.0039
702 CYANOSIS 61 0.0039
703 MADAROSIS 45 0.0039
704 FAECES DISCOLOURED 84 0.0039
705 DEPRESSION 881 0.0039
706 FLATULENCE 219 0.0039
707 EATING DISORDER 82 0.0038
708 ACTIVITIES OF DAILY LIVING IMPAIRED 76 0.0038
709 POLLAKIURIA 160 0.0038
710 MUSCULOSKELETAL DISORDER 73 0.0038
711 HAEMATURIA 131 0.0038
712 PRURITUS 1459 0.0038
713 SYNCOPE 379 0.0038
714 SEPSIS 420 0.0038
715 PRODUCT ADMINISTRATION ERROR 76 0.0038
716 BONE PAIN 220 0.0038
717 OESOPHAGITIS 41 0.0037
718 VISION BLURRED 515 0.0037
719 HAEMATOMA 97 0.0037
720 EYE PAIN 211 0.0037
721 RASH MACULAR 130 0.0037
722 HYPOAESTHESIA 556 0.0037
723 MEDICATION ERROR 206 0.0037
724 INTRAOCULAR PRESSURE INCREASED 47 0.0037
725 JOINT STIFFNESS 96 0.0037
726 VISUAL IMPAIRMENT 453 0.0037
727 NEOPLASM 42 0.0037
728 ABDOMINAL DISTENSION 381 0.0036
729 DECREASED APPETITE 844 0.0036
730 AMNESIA 236 0.0036
731 PRODUCT USE IN UNAPPROVED INDICATION 896 0.0036
732 STOMATITIS 219 0.0036
733 DEHYDRATION 479 0.0036
734 BURNING SENSATION 251 0.0036
735 BLINDNESS 145 0.0036
736 PALLOR 96 0.0035
737 INCORRECT ROUTE OF DRUG ADMINISTRATION 126 0.0035
738 INJURY 247 0.0035
739 HYPOKINESIA 51 0.0035
740 BRAIN FOG 55 0.0035
741 INCREASED APPETITE 67 0.0035
742 NAUSEA 2761 0.0035
743 SKIN ULCER 90 0.0035
744 SKIN REACTION 49 0.0035
745 OCULAR HYPERAEMIA 165 0.0035
746 URINARY INCONTINENCE 103 0.0035
747 DIARRHOEA 2235 0.0035
748 PRODUCT DOSE OMISSION IN ERROR 98 0.0035
749 EXTRA DOSE ADMINISTERED 140 0.0035
750 THERAPEUTIC PRODUCT EFFECT DECREASED 154 0.0034
751 CORONARY ARTERY DISEASE 104 0.0034
752 PRODUCT AVAILABILITY ISSUE 78 0.0034
753 FEAR 92 0.0034
754 MOUTH ULCERATION 72 0.0034
755 MYOCARDIAL INFARCTION 596 0.0034
756 BONE DENSITY DECREASED 107 0.0034
757 BLISTER 191 0.0034
758 ANGER 115 0.0034
759 LYMPHOPENIA 48 0.0034
760 TOOTH EXTRACTION 42 0.0034
761 PSYCHOMOTOR HYPERACTIVITY 56 0.0034
762 HOT FLUSH 253 0.0034
763 TINNITUS 154 0.0033
764 PERIPHERAL COLDNESS 46 0.0033
765 ANGIOEDEMA 148 0.0033
766 CARDIOGENIC SHOCK 48 0.0033
767 TOOTH LOSS 69 0.0033
768 BLOOD POTASSIUM INCREASED 54 0.0033
769 HYPOAESTHESIA ORAL 50 0.0033
770 THIRST 59 0.0033
771 SKIN CANCER 71 0.0033
772 ARRHYTHMIA 156 0.0033
773 HAEMOGLOBIN DECREASED 338 0.0033
774 HYPOPHAGIA 84 0.0033
775 LYMPHOCYTE COUNT DECREASED 58 0.0033
776 PROCEDURAL PAIN 91 0.0033
777 EXPOSURE VIA SKIN CONTACT 85 0.0033
778 OFF LABEL USE 2872 0.0033
779 SOMNOLENCE 660 0.0033
780 GENERAL PHYSICAL HEALTH DETERIORATION 378 0.0033
781 LEUKOCYTOSIS 59 0.0033
782 PRESCRIBED UNDERDOSE 65 0.0033
783 SKIN EXFOLIATION 274 0.0032
784 HYPOTENSION 649 0.0032
785 LYMPHOMA 50 0.0032
786 ADVERSE EVENT 298 0.0032
787 LETHARGY 186 0.0032
788 EYE IRRITATION 186 0.0032
789 UNEVALUABLE EVENT 244 0.0032
790 DEAFNESS 84 0.0032
791 DRY SKIN 427 0.0032
792 GASTRITIS 84 0.0032
793 HAEMATOCHEZIA 176 0.0032
794 MUSCULAR WEAKNESS 361 0.0032
795 DRUG PRESCRIBING ERROR 61 0.0032
796 GLOMERULAR FILTRATION RATE DECREASED 39 0.0032
797 CEREBROVASCULAR ACCIDENT 537 0.0032
798 NEOPLASM MALIGNANT 211 0.0032
799 ABNORMAL DREAMS 87 0.0031
800 IMPAIRED HEALING 102 0.0031
801 DERMATITIS 65 0.0031
802 ALOPECIA 606 0.0031
803 ADVERSE DRUG REACTION 277 0.0031
804 FLUSHING 313 0.0031
805 BLOOD CREATININE INCREASED 201 0.0031
806 THERAPEUTIC RESPONSE SHORTENED 102 0.0031
807 PARAESTHESIA 483 0.0031
808 HAEMORRHAGE 317 0.0030
809 SKIN FISSURES 59 0.0030
810 URINARY RETENTION 100 0.0030
811 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 213 0.0030
812 INCORRECT DOSE ADMINISTERED 683 0.0030
813 GASTROINTESTINAL DISORDER 268 0.0030
814 MENTAL DISORDER 130 0.0030
815 INJECTION SITE PRURITUS 200 0.0030
816 INJECTION SITE BRUISING 238 0.0030
817 APHASIA 90 0.0030
818 DEVICE USE ISSUE 52 0.0030
819 CONFUSIONAL STATE 479 0.0030
820 FREQUENT BOWEL MOVEMENTS 80 0.0030
821 SYSTEMIC LUPUS ERYTHEMATOSUS 105 0.0030
822 INTERSTITIAL LUNG DISEASE 143 0.0030
823 LABORATORY TEST ABNORMAL 87 0.0029
824 DYSSTASIA 86 0.0029
825 DRUG EFFECT DECREASED 158 0.0029
826 DISTURBANCE IN ATTENTION 158 0.0029
827 IRRITABILITY 176 0.0029
828 ASCITES 86 0.0029
829 DEVICE OCCLUSION 41 0.0029
830 BLINDNESS UNILATERAL 41 0.0029
831 FEMUR FRACTURE 90 0.0029
832 FULL BLOOD COUNT DECREASED 58 0.0029
833 MUSCLE TWITCHING 66 0.0029
834 PELVIC PAIN 52 0.0029
835 INJECTION SITE SWELLING 219 0.0029
836 ACUTE MYOCARDIAL INFARCTION 84 0.0028
837 INJECTION SITE RASH 87 0.0028
838 DRUG EFFECT LESS THAN EXPECTED 42 0.0028
839 INJECTION SITE WARMTH 58 0.0028
840 COLON CANCER 42 0.0028
841 BLOOD GLUCOSE INCREASED 530 0.0028
842 BLOOD UREA INCREASED 47 0.0028
843 HYPONATRAEMIA 158 0.0028
844 VISUAL ACUITY REDUCED 93 0.0028
845 IRRITABLE BOWEL SYNDROME 60 0.0028
846 SUICIDAL IDEATION 256 0.0028
847 ANAPHYLACTIC SHOCK 72 0.0028
848 INJECTION SITE URTICARIA 68 0.0028
849 MENTAL IMPAIRMENT 67 0.0028
850 BLOOD GLUCOSE ABNORMAL 51 0.0028
851 TASTE DISORDER 56 0.0028
852 ORTHOSTATIC HYPOTENSION 48 0.0028
853 NIGHTMARE 95 0.0027
854 ANAEMIA 523 0.0027
855 DEEP VEIN THROMBOSIS 178 0.0027
856 ERUCTATION 53 0.0027
857 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 92 0.0027
858 HAEMATEMESIS 69 0.0027
859 HEPATIC CIRRHOSIS 51 0.0027
860 DIABETES MELLITUS INADEQUATE CONTROL 48 0.0027
861 PNEUMONIA ASPIRATION 67 0.0027
862 SENSORY DISTURBANCE 43 0.0027
863 PRODUCT USE COMPLAINT 42 0.0027
864 BLOOD GLUCOSE DECREASED 128 0.0027
865 SEIZURE 307 0.0027
866 PARALYSIS 38 0.0027
867 INJECTION SITE PAIN 813 0.0026
868 DISORIENTATION 105 0.0026
869 CARDIAC FAILURE 212 0.0026
870 LOCAL SWELLING 46 0.0026
871 MENTAL STATUS CHANGES 73 0.0026
872 DELIRIUM 91 0.0026
873 CHROMATURIA 59 0.0026
874 DEVICE ISSUE 234 0.0026
875 DEVICE RELATED INFECTION 40 0.0026
876 INJECTION SITE ERYTHEMA 322 0.0026
877 PANCREATITIS 136 0.0026
878 INJECTION SITE MASS 95 0.0026
879 PRODUCT PRESCRIBING ERROR 61 0.0026
880 PRODUCT SUBSTITUTION ISSUE 146 0.0025
881 CRYING 92 0.0025
882 EMOTIONAL DISORDER 78 0.0025
883 INJECTION SITE REACTION 172 0.0025
884 INTERNATIONAL NORMALISED RATIO INCREASED 71 0.0025
885 SKIN IRRITATION 114 0.0025
886 HALLUCINATION 187 0.0025
887 AGITATION 181 0.0025
888 DRUG DOSE OMISSION BY DEVICE 192 0.0024
889 PRODUCT PRESCRIBING ISSUE 53 0.0024
890 PRODUCT DISPENSING ERROR 52 0.0024
891 ABSCESS 38 0.0024
892 LIVER DISORDER 105 0.0024
893 EMOTIONAL DISTRESS 286 0.0024
894 THERAPY NON-RESPONDER 105 0.0023
895 CARDIAC ARREST 192 0.0023
896 PERICARDITIS 39 0.0023
897 C-REACTIVE PROTEIN INCREASED 84 0.0023
898 OSTEONECROSIS 75 0.0023
899 COLITIS ULCERATIVE 102 0.0023
900 HYPOKALAEMIA 104 0.0023
901 HYPOCALCAEMIA 42 0.0022
902 FRACTURE 42 0.0022
903 COLITIS 84 0.0022
904 RESTLESSNESS 81 0.0022
905 NEEDLE ISSUE 64 0.0022
906 HYPERGLYCAEMIA 80 0.0022
907 ABNORMAL BEHAVIOUR 86 0.0022
908 MOOD ALTERED 59 0.0022
909 RASH GENERALISED 56 0.0022
910 DIPLOPIA 56 0.0022
911 PSORIATIC ARTHROPATHY 86 0.0021
912 MULTIPLE ORGAN DYSFUNCTION SYNDROME 60 0.0021
913 AGGRESSION 105 0.0021
914 DEATH 1776 0.0021
915 PRODUCT PREPARATION ERROR 42 0.0020
916 MATERNAL EXPOSURE DURING PREGNANCY 182 0.0020
917 THERAPY INTERRUPTED 145 0.0020
918 ACNE 152 0.0020
919 LIVER FUNCTION TEST ABNORMAL 58 0.0020
920 SEPTIC SHOCK 86 0.0020
921 PAIN OF SKIN 53 0.0020
922 RENAL IMPAIRMENT 164 0.0020
923 ABDOMINAL PAIN LOWER 49 0.0019
924 COGNITIVE DISORDER 90 0.0019
925 LEUKOPENIA 96 0.0019
926 RASH PAPULAR 43 0.0019
927 MELAENA 42 0.0019
928 BREAST CANCER 174 0.0019
929 WITHDRAWAL SYNDROME 78 0.0019
930 BLOOD ALKALINE PHOSPHATASE INCREASED 46 0.0019
931 MOOD SWINGS 59 0.0018
932 DYSARTHRIA 69 0.0018
933 ACCIDENTAL OVERDOSE 66 0.0018
934 TRANSAMINASES INCREASED 40 0.0018
935 INJECTION SITE HAEMORRHAGE 143 0.0018
936 NO ADVERSE EVENT 320 0.0018
937 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 96 0.0017
938 COMA 83 0.0017
939 PLASMA CELL MYELOMA 68 0.0017
940 WHITE BLOOD CELL COUNT DECREASED 187 0.0017
941 MULTIPLE SCLEROSIS 81 0.0017
942 PROSTATE CANCER 135 0.0017
943 GLYCOSYLATED HAEMOGLOBIN INCREASED 42 0.0017
944 PLATELET COUNT DECREASED 177 0.0017
945 HYPERKALAEMIA 58 0.0017
946 SEDATION 43 0.0016
947 RENAL FAILURE ACUTE 69 0.0016
948 PSYCHOTIC DISORDER 48 0.0016
949 DYSKINESIA 66 0.0016
950 DRUG INTERACTION 256 0.0016
951 MULTIPLE SCLEROSIS RELAPSE 110 0.0016
952 CEREBRAL HAEMORRHAGE 56 0.0016
953 CARDIO-RESPIRATORY ARREST 65 0.0016
954 PRODUCT STORAGE ERROR 136 0.0016
955 HYPOGLYCAEMIA 75 0.0015
956 DEVICE BREAKAGE 62 0.0015
957 ASPARTATE AMINOTRANSFERASE INCREASED 81 0.0015
958 ACCIDENTAL EXPOSURE TO PRODUCT 156 0.0015
959 NERVOUS SYSTEM DISORDER 47 0.0015
960 CARDIOVASCULAR DISORDER 38 0.0015
961 INCORRECT DOSE ADMINISTERED BY DEVICE 39 0.0015
962 BLOOD CREATINE PHOSPHOKINASE INCREASED 42 0.0015
963 DISEASE PROGRESSION 172 0.0015
964 WRONG TECHNIQUE IN DRUG USAGE PROCESS 52 0.0014
965 ABORTION SPONTANEOUS 57 0.0014
966 DEPRESSED LEVEL OF CONSCIOUSNESS 56 0.0014
967 BLOOD BILIRUBIN INCREASED 38 0.0014
968 NEOPLASM PROGRESSION 47 0.0014
969 BRADYCARDIA 70 0.0013
970 ELECTROCARDIOGRAM QT PROLONGED 47 0.0013
971 HEPATIC FAILURE 39 0.0013
972 NEUTROPHIL COUNT DECREASED 51 0.0013
973 METABOLIC ACIDOSIS 40 0.0012
974 DRUG EXPOSURE DURING PREGNANCY 41 0.0012
975 ALANINE AMINOTRANSFERASE INCREASED 74 0.0012
976 SUICIDE ATTEMPT 73 0.0012
977 DEVICE DISLOCATION 51 0.0012
978 DEVICE LEAKAGE 50 0.0012
979 VAGINAL HAEMORRHAGE 49 0.0011
980 PANCYTOPENIA 62 0.0011
981 SKIN BURNING SENSATION 75 0.0010
982 CONVULSION 59 0.0010
983 RENAL CANCER 45 0.0009
984 DRUG WITHDRAWAL SYNDROME 78 0.0009
985 MALIGNANT NEOPLASM PROGRESSION 89 0.0009
986 BLADDER CANCER 50 0.0008
987 NEUTROPENIA 96 0.0007
988 DRUG DEPENDENCE 107 0.0007
989 INTENTIONAL OVERDOSE 41 0.0006
990 DRUG ABUSE 45 0.0005
991 TOXICITY TO VARIOUS AGENTS 74 0.0004